Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Slovenia New bill would regulate cannabis for medical and scientific purposes ...
  • Austria Cannabis association says Tobacco Monopoly Act shouldn’t apply to hemp flowers ...
  • Europe European Council approves omnibus package on sustainability ...
  • United Kingdom FSA response to CTA brings progress and clarification to CBD regulation ...
  • Arkansas - United States Governor vetoes medical cannabis delivery bill ...
  • Kazakhstan Allowing cultivation of low-THC industrial hemp variety being discussed ...
  • Italy TAR rejects appeal against decree on CBD classification ...
  • Minnesota - United States OCM cannabis rules published, licence issuing can begin ...
  • United Kingdom MHRA makes statement about CBD-containing products ...
  • Israel Custom duty to be placed on Canadian medical cannabis imports ...
  • Italy Security Bill text published in Official Gazette ...
  • Kansas - United States Governor calls on legislature to legalise medical cannabis ...
News analysis

More regulatory doubts over CBD in US as FDA commissioner steps down

Written by || 7th March 2019 || News analysis | Regulation and legislation | GeographiesNorth America United States

The resignation of Food and Drug Administration (FDA) commissioner Scott Gottlieb adds further uncertainty to the future of federal oversight of CBD in the US
Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Freddie Dawson

Senior contributing editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the CannIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.